SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Jan-23 6:19 PM View: | Advaxis Inc. (ADXS) | 19-Jan-23 | Grant | 46 | -- | -- | 49% 93 to 0.14K | |
23-Jan-23 9:00 PM View: | Old Ayala, Inc (ADXS) | 19-Jan-23 | Disposition | 250 | -- | -- | (100%) 0.25K to 0 | |
14-Oct-22 2:27 PM View: | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Payment of Exercise | 3,562 | $7.51 | $26,750.60 | (< 1%) 770.61K to 767.04K | |
14-Oct-22 2:27 PM View: | Champions Biotechnology, Inc. (CSBR) | 12-Oct-22 | Option Exercise | 8,333 | $3.21 | $26,748.90 | 1% 762.27K to 770.61K | |
19-Oct-21 3:39 PM View: | Champions Biotechnology, Inc. (CSBR) | 15-Oct-21 | Payment of Exercise | 2,629 | $10.08 | $26,500.30 | < 1% 742.98K to 745.61K | < 1% |
19-Oct-21 3:39 PM View: | Champions Biotechnology, Inc. (CSBR) | 15-Oct-21 | Option Exercise | 16,667 | $1.59 | $26,500.50 | 2% 745.61K to 762.27K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 23-Dec-20 | Market Purchase | 4 | $11.56 | $46.24 | 2% 0.25K to 0.25K | |
28-Oct-20 2:53 PM View: | Champions Biotechnology, Inc. (CSBR) | 16-Oct-20 | Payment of Exercise | 10,100 | $9.01 | $91,001.00 | (1%) 758.33K to 748.23K | (23%) |
28-Oct-20 2:53 PM View: | Champions Biotechnology, Inc. (CSBR) | 16-Oct-20 | Option Exercise | 16,667 | $5.46 | $91,001.80 | 2% 741.67K to 758.33K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 14-Sep-20 | Purchase | 1 | $10.70 | $10.70 | < 1% 0.24K to 0.25K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 11-Sep-20 | Purchase | 10 | $10.07 | $100.70 | 4% 0.23K to 0.24K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 14-Aug-20 | Purchase | 5 | $11.07 | $55.35 | 2% 0.23K to 0.23K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 17-Jul-20 | Purchase | 4 | $11.86 | $47.44 | 2% 0.23K to 0.23K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 07-Jul-20 | Purchase | 1 | $9.60 | $9.60 | < 1% 0.23K to 0.23K | |
11-Jan-21 2:12 PM View: | Orgenesis Inc. (ORGS) | 20-May-20 | Market Purchase | 10 | $6.98 | $69.80 | 6% 0.17K to 0.18K | (29%) |
11-Jan-21 2:12 PM View: | Orgenesis Inc. (ORGS) | 13-May-20 | Market Purchase | 70 | $5.96 | $417.20 | 70% 100 to 0.17K | (17%) |
11-Jan-21 2:12 PM View: | Orgenesis Inc. (ORGS) | 12-May-20 | Market Purchase | 90 | $5.90 | $531.00 | 900% 10 to 100 | (16%) |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 12-May-20 | Purchase | 25 | $15.02 | $375.50 | 12% 0.2K to 0.23K | |
08-Mar-21 4:15 PM View: | Old Ayala, Inc (ADXS) | 08-May-20 | Purchase | 200 | $15.27 | $3,054.00 | 100% 0 to 0.2K | |
11-Jan-21 2:12 PM View: | Orgenesis Inc. (ORGS) | 07-May-20 | Market Purchase | 10 | $5.42 | $54.20 | 100% 0 to 10 | (9%) |
27-Jun-18 5:15 PM View: | Advaxis Inc. (ADXS) | 26-Jun-18 | Grant | 15,000 | -- | -- | 16% 95.36K to 110.36K | |
14-Jun-18 4:30 PM View: | Advaxis Inc. (ADXS) | 13-Jun-18 | Grant | 5,000 | $1.71 | $8,550.00 | 6% 90.36K to 95.36K | (98%) |
13-Jun-18 6:36 PM View: | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 10,000 | $1.84 | $18,432.00 | 12% 80.36K to 90.36K | (98%) |
10-Aug-16 7:30 PM View: | Advaxis Inc. (ADXS) | 09-Aug-16 | Market Sale | 11,404 | $14.85 | $169,349.00 | (12%) 91.76K to 80.36K | 100% |
10-Aug-16 7:30 PM View: | Advaxis Inc. (ADXS) | 08-Aug-16 | Market Sale | 11,404 | $15.17 | $172,999.00 | (11%) 103.16K to 91.76K | 100% |
06-Nov-15 6:00 PM View: | Advaxis Inc. (ADXS) | 05-Nov-15 | Grant | 2,744 | -- | -- | 3% 100.42K to 103.16K | |
01-Apr-15 6:04 PM View: | Advaxis Inc. (ADXS) | 30-Mar-15 | Grant | 15,000 | -- | -- | 18% 85.42K to 100.42K | |
12-Jan-15 5:16 PM View: | Immune Pharmaceuticals, Inc. (IMNPQ) | 08-Jan-15 | Grant | 3,409 | -- | -- | 19% 18.29K to 21.7K | |
03-Dec-14 4:54 PM View: | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 10,400 | $2.50 | $26,000.00 | 132% 7.89K to 18.29K | 40% |
04-Feb-15 9:50 PM View: | Advaxis Inc. (ADXS) | 03-Nov-14 | Grant | 25,115 | -- | -- | 42% 60.3K to 85.42K | |
18-Jul-14 5:12 PM View: | Advaxis Inc. (ADXS) | 17-Jul-14 | Grant | 50,000 | -- | -- | 485% 10.3K to 60.3K | |
26-Nov-13 9:59 AM View: | Advaxis Inc. (ADXS) | 18-Nov-13 | Grant | 10,309 | $4.85 | $49,998.60 | 100% 0 to 10.31K | |
20-Sep-13 12:48 PM View: | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 1,000 | -- | -- | (100%) 1.0K to 0 | |
28-Aug-13 12:09 PM View: | Immune Pharmaceuticals, Inc. (IMNPQ) | 25-Aug-13 | Grant | 5,951 | -- | -- | 100% 0 to 5.95K | |
18-Jul-11 4:05 PM View: | Champions Biotechnology, Inc. (CSBR) | 14-Jul-11 | Grant | 100,000 | -- | -- | < 1% 10.57M to 10.68M | |
08-Jul-10 4:02 PM View: | KV Pharmaceutical Co. (KVA/KVB) | 02-Jul-10 | Grant | 7,500 | -- | -- | 750% 1.0K to 8.5K | |
29-May-07 1:18 PM View: | Champions Biotechnology, Inc. (CSBR) | 17-May-07 | Acquisition (other) | 3,800,000 | -- | -- | 54% 7.0M to 10.8M | |
16-Jun-08 10:00 PM View: | Champions Biotechnology, Inc. (CSBR) | 01-May-07 | Gift | 200,000 | -- | -- | (2%) 10.8M to 10.6M | |
07-Mar-06 4:28 PM View: | Alfacell Corp. (ACEL) | 07-Mar-06 | Option Exercise | 5,000 | $3.46 | $17,300.00 | 12% 40.0K to 45.0K | (87%) |